<DOC>
	<DOCNO>NCT00719602</DOCNO>
	<brief_summary>More 1.5 million death African child 5 year age due Plasmodium falciparum malaria . When HIV malaria present coinfections , enhance 's progression . The primary purpose study compare malarial infection level HIV-infected infant child receive protease inhibitor ( PI ) - non-nucleotide reverse transcriptase inhibitor ( NNRTI ) -based highly active antiretroviral therapy ( HAART ) .</brief_summary>
	<brief_title>Differences Malaria Infection Levels HIV-infected Infants Children Receiving PI- NNRTI-based HAART</brief_title>
	<detailed_description>The World Health Organization ( WHO ) report 1 2 million malaria death annually , malaria-related death occur child . The malaria burden compound HIV epidemic , prevalent area endemic malaria , notably Sub-Saharan Africa nine ten child young 15 year age infect HIV . The purpose study compare parasitemia level HIV-infected infant child receive PI- NNRTI-based HAART regimens . This study enroll total 140 participant , 35 4 group IMPAACT P1060 . This substudy last 24 week last P1060 enrollment P1060 study discontinuation . Participants must meet enrollment criterion P1060 well additional criterion study . Study visit occur part P1060 study visit , include physical exam , blood collection , assessments HIV-related symptom . Participants also encourage return primary clinic site intercurrent illness visit assessment , thick thin blood smear , filter paper blood collection , however visit mandatory study participation .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Enrolling study IMPAACT P1060 Parent/legal guardian agree seek medical care intercurrent illness study site , whenever possible , agree use athome remedy febrile illness child</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Coinfection</keyword>
</DOC>